Items Tagged ‘Metastatic Stage IV (D) Prostate Cancer’

November 30, 2010

Xgeva Approved for Patients with Bone Metastases

By

Xgeva™ (denosumab) has been approved by the US Food and Drug Administration (FDA) for the prevention of bone complications such as fracture in patients with bone metastases from solid (not blood-related) cancers. It is not approved for patients with multiple myeloma or other cancers of the blood. Metastatic cancer refers to cancer that has spread […]

View full entry

Tags: Breast Cancer, Management and Prevention of Bone Complications Supportive Care, Metastatic Breast Cancer, Metastatic Stage IV (D) Prostate Cancer, Prostate Cancer, Supportive Care


October 20, 2008

Body Weight and C-Peptide Levels Associated with Risk of Dying from Prostate Cancer

By

Body Weight and C-Peptide Levels Associated with Risk of Dying from Prostate Cancer Excess body weight coupled with a high C-peptide level among men with prostate cancer is associated with an increased risk of death from the disease. These results were recently published in an early online version of the Lancet Oncology. The prostate is […]

View full entry

Tags: Early Stage I-II (A-B) Prostate Cancer, Locally Advanced Stage III (C) Prostate Cancer, Metastatic Stage IV (D) Prostate Cancer, Refactory/Recurrent Prostate Cancer, Screening/Prevention Prostate Cancer